No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
818 |
4. Check minimum number of eventsNone |
818 |
5. Include endpointsNone |
818 |
6. Filter based on genotype QC (FinnGen only) |
677 |
Control definitions (FinnGen only)
- Control exclude
- AB1_PROTOZOAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Pneumocystosis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Pneumocystosis
- Protozoal diseases
- Protozoal diseases, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 677 | 304 | 373 |
| Unadjusted period prevalence (%) | 0.14 | 0.11 | 0.17 |
| Median age at first event (years) | 68.91 | 68.36 | 69.36 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 701
- Matched controls
- 7010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
23.1
307.7
293
211
TGC00
NOMESCO Finland
Bronchial lavation
54.9
307.7
312
101
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.9
307.7
349
349
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
608
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.0
274.4
243
181
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.7
261.4
250
213
J18.9
ICD-10 Finland
Pneumonia, unspecified
11.3
218.0
511
1352
R50.9
ICD-10 Finland
Fever, unspecified
8.7
181.8
341
686
ZX108
NOMESCO Finland
Inhalation
48.4
169.2
100
24
XW000
NOMESCO Finland
Bone marrow biopsy
13.5
165.2
174
167
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.4
162.1
284
523
L03AA02
ATC
filgrastim; parenteral
16.2
155.7
143
109
WW500
NOMESCO Finland
Blood transfusion
12.5
140.8
154
155
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
17.6
134.6
116
78
GD1AD
NOMESCO Finland
Thorax CT examination
8.9
133.3
197
294
B59
ICD-10 Finland
Pneumocystosis
+∞
129.3
120
*
JN4AD
NOMESCO Finland
Body CT examination
6.7
127.4
276
616
ZX120
NOMESCO Finland
Intravenous
7.5
123.7
221
405
H02AB06
ATC
prednisolone; systemic
7.7
115.6
576
2618
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.1
111.9
610
2971
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.5
111.5
235
504
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
14.0
110.5
108
90
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.1
109.9
152
207
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
22.3
100.7
76
38
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.9
99.3
183
341
H02AB02
ATC
dexamethasone; systemic
5.8
96.8
232
554
L04AA06
ATC
mycophenolic acid; systemic
15.6
91.8
83
60
L03AA13
ATC
pegfilgrastim; parenteral
8.7
90.2
126
172
A04AA01
ATC
ondansetron; systemic, rectal
6.3
89.8
181
366
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
89.8
122
161
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.7
89.8
126
173
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
18.3
89.5
74
45
M04AA01
ATC
allopurinol; systemic
5.2
88.6
241
637
D70.82
ICD-10 Finland
Drug-induced neutropenia
17.4
88.4
75
48
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
88.3
292
904
J01MA14
ATC
moxifloxacin; systemic
6.2
87.7
182
378
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
86.5
145
243
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.2
85.5
173
350
127
Kela drug reimbursment
Transplant complication
17.8
85.0
71
44
JN4BD
NOMESCO Finland
Extensive body CT
5.4
84.1
208
505
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
13.2
79.4
79
67
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.8
79.4
98
114
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
30.1
79.2
53
19
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
78.4
311
1089
Z51.5
ICD-10 Finland
Palliative care
5.4
76.3
181
421
L04AX01
ATC
azathioprine; systemic
8.7
71.0
96
125
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
14.5
69.9
65
49
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.8
67.9
91
117
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.1
67.8
134
262
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.6
67.6
55
32
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
67.5
403
1827
J01MA12
ATC
levofloxacin; systemic
4.1
66.1
262
899
J01FF01
ATC
clindamycin; systemic
3.8
65.9
330
1328
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
63.4
174
452
D70.89
ICD-10 Finland
Neutropenic splenomegaly
18.9
63.3
51
29
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
25.2
63.3
45
19
C03CA01
ATC
furosemide; systemic
3.6
60.8
368
1653
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.5
60.3
183
513
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.6
57.6
78
101
TK800
NOMESCO Finland
Hemodialysis
10.6
57.1
65
67
A04AA02
ATC
granisetron; systemic, transdermal
5.3
56.5
131
294
L04AD01
ATC
ciclosporin; systemic
12.6
56.5
57
49
JN6AD
NOMESCO Finland
CT of torso and neck
10.7
55.9
63
64
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
53.5
198
637
J05AB11
ATC
valaciclovir; oral
3.9
53.1
201
656
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
21.1
52.4
40
20
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.3
51.5
46
32
WW200
NOMESCO Finland
Immunization
9.3
50.2
63
74
WZC00
NOMESCO Finland
Treatment plan or consultation
3.2
49.0
385
1953
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
46.6
271
1149
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.0
44.8
57
68
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.9
44.6
42
32
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.5
44.0
66
96
L03AA14
ATC
lipegfilgrastim; parenteral
9.6
43.9
53
59
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.6
43.9
53
59
L04AA01
ATC
[U] ciclosporin
15.2
43.7
39
27
A02BC02
ATC
pantoprazole; systemic
4.1
42.6
600
4127
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.1
41.3
52
61
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
11.7
41.0
43
39
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.9
41.0
100
232
ZX112
NOMESCO Finland
Subcutaneous
7.5
40.4
60
86
N02AA05
ATC
oxycodone; systemic
3.1
40.1
235
987
L04AX03
ATC
methotrexate; systemic
4.0
40.1
133
390
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
40.0
98
228
R06.0
ICD-10 Finland
Dyspnoea
2.9
39.9
304
1474
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
39.7
231
966
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.8
39.4
51
62
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.6
39.3
52
65
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
38.8
73
134
Z94.0
ICD-10 Finland
Kidney transplant status
14.0
38.5
36
27
WX892
NOMESCO Finland
Monitored bed care
4.2
38.4
117
322
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
11.7
38.3
40
36
A07EC01
ATC
sulfasalazine; oral, rectal
4.3
36.3
105
278
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.8
36.0
88
204
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.8
35.4
39
38
B03XA01
ATC
erythropoietin; parenteral
13.8
35.0
33
25
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.6
34.5
89
215
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.3
34.4
52
76
A07AA09
ATC
vancomycin; oral
11.1
34.2
37
35
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.9
34.2
32
24
L01BA01
ATC
methotrexate; systemic
6.3
34.1
60
103
B03XA02
ATC
darbepoetin alfa; parenteral
7.3
33.5
51
75
L04AD02
ATC
tacrolimus; systemic
12.8
33.5
33
27
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.1
33.3
74
158
H02AB09
ATC
hydrocortisone; systemic
7.6
33.0
48
67
C90.0
ICD-10 Finland
Multiple myeloma
10.5
33.0
37
37
H02AB07
ATC
prednisone; oral
3.2
32.1
154
569
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.9
30.9
58
106
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
30.8
443
2822
A11CC03
ATC
alfacalcidol; systemic
6.8
29.8
48
75
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.8
29.3
47
73
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
28.8
120
405
L04AA13
ATC
[U] leflunomide
7.2
28.7
44
65
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
27.4
28.7
39
15
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.6
28.6
30
27
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.9
28.5
92
262
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
28.2
284
1521
M05BX04
ATC
denosumab; parenteral
3.9
27.6
89
253
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
27.6
138
519
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.6
27.6
33
36
B01AB10
ATC
tinzaparin; parenteral
3.1
27.5
137
514
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.9
27.4
64
142
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
27.3
153
613
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
27.2
89
256
P01BA02
ATC
hydroxychloroquine; oral
3.5
27.1
102
322
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
27.1
145
566
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.9
26.8
34
40
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.0
26.8
81
220
Z2446
NOMESCO Finland
Social worker
3.9
26.5
85
241
H02AB04
ATC
methylprednisolone; systemic
2.9
26.2
152
619
1CX01, ,
NOMESCO Finland
62.6
26.2
30
5
J05AB01
ATC
aciclovir; systemic
2.5
26.0
208
996
WW300
NOMESCO Finland
Transfer of autologic stem cells
29.7
25.6
34
12
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.8
25.5
84
242
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.8
25.5
28
27
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.3
25.1
52
104
A12AA04
ATC
calcium carbonate; oral
7.2
24.4
37
54
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.2
24.3
30
34
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
24.1
128
496
1XC02, ,
NOMESCO Finland
22.3
23.6
34
16
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.5
23.3
46
88
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
23.1
351
2190
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.9
23.1
32
42
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
23.0
22
*
B48.5
ICD-10 Finland
Pneumocystosis
+∞
23.0
22
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.2
22.4
39
66
L04AB04
ATC
adalimumab; parenteral
7.3
22.2
33
47
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
7.6
22.2
32
44
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
22.2
99
346
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.5
22.1
84
266
A05AA02
ATC
ursodeoxycholic acid; oral
8.0
21.8
30
39
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
21.7
186
910
R4110
NOMESCO Finland
Physiotherapy
2.2
21.6
259
1462
WX720
NOMESCO Finland
Own respiration
3.7
21.3
73
216
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.4
21.2
43
84
Z3231
NOMESCO Finland
Registered nurse
2.2
21.0
246
1371
J96.0
ICD-10 Finland
Acute respiratory failure
7.3
20.9
31
44
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
20.8
119
477
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
20.8
39
71
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.5
20.6
27
33
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
43.1
20.6
25
6
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.1
20.4
44
91
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
20.3
108
417
A04AA55
ATC
palonosetron, combinations; systemic
4.3
20.0
53
130
SPAT1255
SPAT
Intravenous administration of medicine
3.4
20.0
78
251
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.0
19.6
57
150
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
19.4
125
532
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
32.3
19.4
25
8
L04AB01
ATC
etanercept; parenteral
8.6
19.4
25
30
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
19.3
187
959
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
19.2
243
1388
C83.1
ICD-10 Finland
Mantle cell lymphoma
23.3
19.2
27
12
ZXE00
NOMESCO Finland
One hour or less
2.1
19.1
309
1935
6BA02, ,
NOMESCO Finland
56.7
19.0
22
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.0
19.0
34
59
A07AA02
ATC
nystatin; oral
3.5
19.0
70
217
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
18.9
301
1873
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
18.9
48
114
B01AB05
ATC
enoxaparin; parenteral
2.1
18.8
283
1722
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
71.9
18.8
21
*
R81
ICPC
Pneumonia
4.0
18.8
56
150
A03
ICPC
Fever
2.4
18.7
146
681
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
18.5
78
263
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
18.0
158
775
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.7
17.9
27
15
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
18.7
17.9
27
15
B02.9
ICD-10 Finland
Zoster without complication
3.0
17.8
84
302
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.5
17.5
63
192
J02AC03
ATC
voriconazole; systemic
24.8
17.4
24
10
A46
ICD-10 Finland
Erysipelas
2.4
17.3
146
702
212
Kela drug reimbursment
Gout
5.6
17.3
33
61
WZC30
NOMESCO Finland
Teaching
2.3
17.1
162
819
ZX120, ,
SPAT
7.4
17.0
25
35
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.9
16.9
31
55
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.3
16.9
147
716
R03AC02
ATC
salbutamol; inhalant
2.0
16.4
418
3012
J01MA02
ATC
ciprofloxacin; systemic
1.9
16.3
317
2087
390
Kela drug reimbursment
Ibrutinib
48.7
16.1
19
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
21.6
16.1
23
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.1
16.0
72
252
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
15.9
40
94
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
15.8
35
74
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.3
15.7
32
63
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.7
15.4
29
53
N17.8
ICD-10 Finland
Other acute renal failure
7.2
15.3
23
33
N05CF01
ATC
zopiclone; oral
2.0
15.3
256
1593
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
15.2
120
559
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
15.1
220
1303
XQ855, ,
SPAT
6.7
15.0
24
37
WX882
NOMESCO Finland
High dependency care
4.2
14.9
40
99
A04AD12
ATC
aprepitant; systemic
5.0
14.9
32
66
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
14.9
48
136
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
14.8
69
246
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
14.8
43
113
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
13.6
14.8
25
19
329
Kela drug reimbursment
Lenalidomide
18.9
14.8
22
12
L01AA02
ATC
chlorambucil; oral
25.7
14.7
20
8
Z3226
NOMESCO Finland
Physiotherapist
2.1
14.7
160
851
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.2
14.7
26
22
A10AC01
ATC
insulin (human); parenteral
2.8
14.5
77
295
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.4
14.5
37
88
WX726
NOMESCO Finland
High-flow oxygen therapy
36.9
14.5
18
5
153
Kela drug reimbursment
Lenalidomid
12.9
14.5
25
20
M05BA04
ATC
alendronic acid; oral
2.7
14.4
86
350
R05
ICD-10 Finland
Cough
2.0
14.2
182
1026
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
14.2
133
665
1512
Kela drug reimbursment
Ibrutinib
43.4
14.2
17
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
14.1
96
417
J01DB01
ATC
cefalexin; oral
2.3
14.0
597
5006
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
14.0
47
137
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
24.4
13.8
19
8
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
13.9
13.8
23
17
A06AH03
ATC
naloxegol; oral
5.9
13.8
25
44
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.3
13.7
28
55
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
13.7
220
1340
J01CA04
ATC
amoxicillin; systemic
2.2
13.7
581
4834
L04AX04
ATC
lenalidomide; oral
12.4
13.7
24
20
JN4CD
NOMESCO Finland
Very extensive body CT
3.6
13.7
47
139
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.6
13.5
46
135
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
16.6
13.5
21
13
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
13.5
59
203
B34.9
ICD-10 Finland
Viral infection, unspecified
4.6
13.4
32
72
L01AA01
ATC
cyclophosphamide; systemic
18.7
13.4
20
11
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
13.4
51
161
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
13.4
50
156
WW409
NOMESCO Finland
Other aferesis
21.7
13.4
19
9
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
13.4
141
738
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
13.3
39
103
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.0
13.3
26
27
R11
ICD-10 Finland
Nausea and vomiting
2.6
13.2
81
334
C82.1
ICD-10 Finland
Follicular lymphoma grade II
12.5
13.2
23
19
AA1AD
NOMESCO Finland
CT of head and brain
1.9
13.2
256
1656
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
13.1
321
2227
WX725
NOMESCO Finland
Noninvasive ventilation
2.9
13.1
64
234
N18.0
ICD-10 Finland
End-stage renal disease
10.3
13.1
25
25
E87.5
ICD-10 Finland
Hyperkalaemia
5.0
12.9
28
58
N02AA01
ATC
morphine; systemic, rectal
4.7
12.9
30
66
WX002
NOMESCO Finland
Sedation and analgesia
2.0
12.9
170
965
ZXD05
NOMESCO Finland
Urgent procedure
1.9
12.9
227
1422
RD210, ,
NOMESCO Finland
5.6
12.7
24
44
YNB10
NOMESCO Finland
Collection of stem cells for transplant
71.2
12.6
14
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.6
341
2429
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
12.5
12
*
R06AE07
ATC
cetirizine; oral
1.8
12.3
302
2087
Z2221
NOMESCO Finland
Medical doctor
1.9
12.1
205
1263
399
Kela drug reimbursment
Venetoclax
18.4
12.1
18
10
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
8.9
12.1
25
29
A10AB05
ATC
insulin aspart; parenteral
2.6
12.0
76
318
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
12.0
49
162
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
15.0
11.8
19
13
M01CB01
ATC
sodium aurothiomalate; parenteral
9.2
11.8
24
27
L01CA04
ATC
vinorelbine; systemic
9.2
11.8
24
27
C07AB07
ATC
bisoprolol; oral
1.8
11.8
394
2962
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.1
11.8
50
169
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
11.8
25
51
3AC01, ,
NOMESCO Finland
12.8
11.7
20
16
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
30.6
11.7
15
5
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
30.6
11.7
15
5
L01EL01
ATC
ibrutinib; oral
66.1
11.6
13
*
L01XE27
ATC
[U] ibrutinib
66.1
11.6
13
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
11.5
511
4157
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
11.5
11
*
130
Kela drug reimbursment
Malignant tumour
2.3
11.4
93
437
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
17.4
11.2
17
10
1518, ,
Kela drug reimbursment
17.4
11.2
17
10
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
25.5
11.2
15
6
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.4
11.1
22
24
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.3
11.1
21
21
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
14.2
11.0
18
13
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.9
180
1096
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
10.9
79
353
R4190
NOMESCO Finland
Nutritional therapy
3.1
10.8
45
150
C83.00
ICD-10 Finland
Lymphocytic lymphoma
28.5
10.8
14
5
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.2
10.7
42
135
D69.5
ICD-10 Finland
Secondary thrombocytopenia
21.9
10.7
15
7
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
60.9
10.6
12
*
J12.8
ICD-10 Finland
Other viral pneumonia
9.4
10.6
21
23
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.7
10.5
24
52
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.5
10.5
66
275
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.5
10.5
17
12
J04BA02
ATC
dapsone; oral
16.3
10.4
16
10
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.8
10.3
23
49
L01XX52
ATC
venetoclax; oral
19.1
10.3
15
8
V03AE01
ATC
polystyrene sulfonate; oral
5.4
10.2
20
38
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
10.1
42
140
ZXA00
NOMESCO Finland
Right side
1.8
10.1
212
1383
N03AX16
ATC
[U] pregabalin
1.8
10.1
182
1135
R28
ICPC
Limited function/disability (R)
5.1
10.1
21
42
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
10.1
88
425
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.8
10.1
31
85
J02AC01
ATC
fluconazole; systemic
1.7
10.0
240
1624
R02
ICPC
Shortness of breath/dyspnoea
2.0
10.0
122
669
TAB00
NOMESCO Finland
Lumbar puncture
3.0
10.0
46
163
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.0
10.0
44
152
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
40.7
10.0
12
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.9
120
656
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.9
167
1019
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.4
9.9
25
59
A02BC01
ATC
omeprazole; systemic
1.8
9.9
205
1331
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
8.3
9.9
21
26
L01BB05
ATC
fludarabine; systemic
26.4
9.8
13
5
L04AA24
ATC
abatacept; parenteral
20.4
9.8
14
7
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.8
9.8
22
47
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.2
9.8
26
64
WX610
NOMESCO Finland
Patient controlled analgesia
13.6
9.7
16
12
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.7
643
5762
WW400
NOMESCO Finland
Plasmaferesis
55.8
9.7
11
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
9.7
44
155
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
9.6
54
213
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.1
9.6
20
40
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
8.5
9.6
20
24
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
9.6
43
150
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.9
9.6
21
44
M31.3
ICD-10 Finland
Wegener granulomatosis
15.3
9.5
15
10
SPAT1262
SPAT
Handing over of treatment supplies
1.9
9.5
148
881
Z94.2
ICD-10 Finland
Lung transplant status
30.5
9.4
12
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
9.4
69
309
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.1
9.4
22
32
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.1
9.4
22
32
J01AA02
ATC
doxycycline; systemic
1.8
9.4
547
4652
C08CA01
ATC
amlodipine; oral
1.6
9.3
311
2287
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
9.3
127
723
N19
ICD-10 Finland
Unspecified kidney failure
2.9
9.3
43
153
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.2
272
1937
A02BC05
ATC
esomeprazole; systemic
1.6
9.2
295
2145
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
9.2
26
67
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.9
9.2
15
11
UJF32
NOMESCO Finland
Coloscopy
1.7
9.1
207
1374
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
9.1
87
435
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.2
9.1
18
20
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
37.2
9.0
11
*
J96.1
ICD-10 Finland
Chronic respiratory failure
3.6
9.0
29
82
A41.8
ICD-10 Finland
Other specified sepsis
3.9
9.0
26
68
EBA10
NOMESCO Finland
Operative extraction of tooth
2.2
9.0
84
417
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
24.4
8.9
12
5
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
8.9
58
246
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
8.1
8.9
19
24
137
Kela drug reimbursment
Uraemia requiring dialysis
8.1
8.9
19
24
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
8.9
70
324
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
8.9
64
285
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.8
273
1965
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
8.8
48
187
J47
ICD-10 Finland
Bronchiectasis
3.7
8.8
28
79
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.7
8.7
21
32
120
Kela drug reimbursment
Hypogammaglobulinaemia
50.6
8.7
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
8.7
24
61
V03AE02
ATC
sevelamer; oral
11.8
8.6
15
13
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
8.6
52
213
ZXA05
NOMESCO Finland
Left side
1.7
8.6
188
1233
WX402
NOMESCO Finland
General anaesthesia
1.7
8.6
173
1109
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.4
8.6
30
90
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
27.9
8.5
11
*
SPAT1325
SPAT
Vaccination
1.6
8.5
255
1817
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.5
151
934
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.8
8.4
20
30
HA1AA
NOMESCO Finland
X-ray mammography
2.3
8.3
66
306
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
9.6
8.3
16
17
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.5
8.3
28
82
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.3
63
1244
ZX121
NOMESCO Finland
Central venous catheter
14.7
8.2
13
9
R03BB04
ATC
tiotropium bromide; inhalant
2.0
8.2
89
467
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
8.2
44
170
E0000UV, ,
ATC
1.6
8.2
290
2146
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.3
8.2
30
93
A06AD11
ATC
lactulose; oral
1.9
8.1
118
684
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.1
319
2417
RS220, ,
NOMESCO Finland
6.9
8.1
19
28
B01AB04
ATC
dalteparin; parenteral
2.7
8.1
43
165
GDG10
NOMESCO Finland
Bilateral transplantation of lung
33.8
8.1
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
8.1
35
120
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
8.1
25
69
GX1K5
NOMESCO Finland
Diffusion capacity
9.1
8.1
16
18
WPB10
NOMESCO Finland
Making a convalescent care decision
9.1
8.1
16
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.1
78
392
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.8
8.1
40
148
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.0
7.9
22
56
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.7
7.9
19
29
K65.0
ICD-10 Finland
Acute peritonitis
6.7
7.9
19
29
L04AX05
ATC
pirfenidone; oral
13.2
7.9
13
10
V03AE03
ATC
lanthanum carbonate; oral
13.2
7.9
13
10
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
6.2
7.9
20
33
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.2
7.9
20
33
RS221, ,
NOMESCO Finland
6.2
7.9
20
33
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.6
7.9
26
75
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
7.9
59
267
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
8.6
7.8
16
19
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.0
7.7
20
34
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
45.5
7.7
9
*
B73
ICPC
Leukaemia
45.5
7.7
9
*
B74
ICPC
Malignant neoplasm blood other
45.5
7.7
9
*
R03BA08
ATC
ciclesonide; inhalant
2.2
7.6
67
324
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.8
7.6
18
27
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
18.6
7.6
11
6
TPX15
NOMESCO Finland
Removal of vascular injection port
12.0
7.6
13
11
R04.2
ICD-10 Finland
Haemoptysis
2.9
7.5
35
125
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.2
7.5
17
24
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
7.5
39
148
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.5
7.5
18
41
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
7.5
146
925
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
7.5
25
73
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
7.4
48
203
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.8
7.4
16
21
R2110
NOMESCO Finland
Giving the first information
2.5
7.4
46
191
NG1DA
NOMESCO Finland
X-ray of knees
3.8
7.4
22
59
FM1FN
NOMESCO Finland
Heart function isotope examination
13.5
7.4
12
9
L01BC06
ATC
capecitabine; oral
2.6
7.4
41
161
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.1
7.4
20
50
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.5
7.3
15
18
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
7.3
44
180
284
Kela drug reimbursment
Nintedanib and pirfenidone
9.5
7.3
14
15
J15.8
ICD-10 Finland
Other bacterial pneumonia
9.5
7.3
14
15
B05DB
ATC
Hypertonic solutions
9.5
7.3
14
15
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
7.3
57
263
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.3
7.3
18
29
WX722
NOMESCO Finland
PEEP
2.5
7.3
46
193
WVA20
NOMESCO Finland
Medicine administration
3.0
7.3
32
111
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.8
7.2
22
60
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.2
143
910
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.4
7.2
25
75
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
30.3
7.2
9
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
30.3
7.2
9
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
20.3
7.1
10
5
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
7.1
39
152
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
7.1
39
152
N03AX14
ATC
levetiracetam; systemic
3.1
7.1
29
96
WF002
NOMESCO Finland
Radical radiotherapy
2.2
7.1
59
279
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
12.2
7.1
12
10
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.9
7.1
14
16
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
7.0
35
130
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
7.0
40
160
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
13.9
6.9
11
8
ZX080
NOMESCO Finland
Image guided radiotherapy
3.3
6.9
25
77
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.4
6.8
14
17
TGD00
NOMESCO Finland
Needle biopsy of lung
8.4
6.8
14
17
1CD02, ,
NOMESCO Finland
6.8
6.8
16
24
356
Kela drug reimbursment
Nintedanib and pirfenidone
9.4
6.8
13
14
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.2
6.8
17
28
L01BB01, ,
ATC
40.5
6.8
8
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
40.5
6.8
8
*
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
40.5
6.8
8
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
6.8
31
110
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.5
6.7
23
68
J01FA06
ATC
roxithromycin; oral
1.5
6.7
269
2023
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
6.0
6.6
17
29
Z49.2
ICD-10 Finland
Other dialysis
7.9
6.6
14
18
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
6.6
56
267
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.4
6.6
23
69
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.6
263
1976
H05BX01
ATC
cinacalcet; oral
8.8
6.6
13
15
JAH01
NOMESCO Finland
Laparoscopy
2.7
6.6
35
135
D07AC01
ATC
betamethasone; topical
1.5
6.6
253
1886
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
10.2
6.6
12
12
H05AA02
ATC
teriparatide; parenteral
10.2
6.6
12
12
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.5
36
141
A28
ICPC
Limited function/disability NOS
1.7
6.5
142
923
Z51.88
ICD-10 Finland
Other specified medical care
3.7
6.5
20
55
DHA10
NOMESCO Finland
Biopsy of cavity of nose
6.3
6.5
16
26
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.6
6.5
21
60
ZX100
NOMESCO Finland
Oral
4.0
6.5
18
46
M31.1
ICD-10 Finland
Thrombotic microangiopathy
70.5
6.4
7
*
WW402
NOMESCO Finland
Leucoferesis
70.5
6.4
7
*
L04AA10
ATC
[U] sirolimus
70.5
6.4
7
*
ZX131
NOMESCO Finland
Intrathecal
70.5
6.4
7
*
1AA09, ,
NOMESCO Finland
70.5
6.4
7
*
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
7.5
6.4
14
19
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
14.5
6.4
10
7
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
14.5
6.4
10
7
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
14.5
6.4
10
7
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
6.4
185
1292
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.3
6.4
13
16
J46
ICD-10 Finland
Status asthmaticus
3.4
6.3
22
66
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
11.2
6.3
11
10
318
Kela drug reimbursment
Teriparatide
9.4
6.3
12
13
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
9.4
6.3
12
13
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
6.3
6
*
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
SPAT1263
SPAT
Sampling
1.5
6.2
283
2177
H26.3
ICD-10 Finland
Drug-induced cataract
7.1
6.2
14
20
B05DA
ATC
Isotonic solutions
7.1
6.2
14
20
293
Kela drug reimbursment
Baricitinib
26.9
6.2
8
*
3006
Kela drug reimbursment
Baricitinib
26.9
6.2
8
*
L04AA37
ATC
[U] baricitinib
26.9
6.2
8
*
XX2RW, ,
NOMESCO Finland
5.1
6.2
18
36
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
6.2
23
72
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.4
6.2
15
24
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.8
6.1
13
17
ZXA10
NOMESCO Finland
Bilateral
1.7
6.1
133
864
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.7
6.1
10
8
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
8.7
6.1
12
14
TK820
NOMESCO Finland
Peritoneal dialysis
8.7
6.1
12
14
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.8
6.1
14
21
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.1
6.0
11
11
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
214
84
36.23
320.38
2.4
1.6
—
—
—
0
0
175
33
70.34
315.96
1.3
1.3
—
—
—
0
0
232
120
28.40
312.97
3.8
3.5
883.50
2617.00
u/ml
0.42
20
11
236
89
39.47
307.65
2.4
1.6
—
—
—
0
0
374
185
42.19
307.65
2.8
1.6
—
—
—
0
0
373
197
39.33
307.65
2.9
1.7
—
—
—
0
0
484
68
227.70
307.65
1.9
1.6
—
—
—
0
0
349
148
45.97
307.65
2.2
1.5
—
—
—
0
0
336
148
42.68
307.65
7.2
7.0
362.34
318.31
iu/ml
0.11
76
26
283
124
37.60
307.65
2.8
1.9
—
—
—
0
0
292
126
39.01
307.65
2.3
1.6
—
—
—
0
0
367
286
25.83
307.65
3.4
2.9
—
—
—
0
0
295
149
33.46
307.65
2.4
1.5
—
—
—
0
0
375
172
45.73
307.65
2.3
1.5
—
—
—
0
0
251
178
21.41
291.77
2.0
1.4
—
—
—
0
0
173
57
39.97
272.23
3.0
1.9
1039.75
1230.14
e6/l
0.46
167
50
459
892
13.01
267.34
3.9
2.0
—
—
—
0
0
153
40
48.65
255.94
2.5
1.9
—
—
—
0
0
463
951
12.39
255.40
3.7
1.9
—
—
—
0
0
517
1234
13.15
249.50
4.5
2.0
—
—
—
0
0
147
41
45.10
241.52
3.8
2.4
35.79
42.86
%
1.52
94
25
346
554
11.36
231.41
7.3
2.8
8.31
10.93
g/l
10.40
341
513
131
47
34.05
199.04
2.4
1.6
—
—
—
0
0
251
332
11.22
191.74
3.1
2.0
0.95
2.21
ug/l
0.76
239
300
120
38
37.89
189.23
2.5
1.7
—
—
—
0
0
388
876
8.68
186.31
12.2
4.4
270.63
255.11
u/l
0.73
381
838
139
71
24.17
184.96
3.0
2.0
—
—
—
0
0
141
75
23.28
184.38
3.0
2.0
—
—
—
0
0
119
40
35.63
184.22
2.5
1.7
—
—
—
0
0
133
64
25.41
181.28
1.4
1.3
—
—
—
0
0
124
52
28.76
178.11
2.5
1.7
—
—
—
0
0
104
35
34.72
160.46
1.6
2.0
96558.80
74250.67
u/ml
—
25
6
106
44
28.20
152.27
3.5
2.0
218.96
208.16
e6/l
0.10
101
38
252
444
8.30
148.53
3.4
1.7
1.02
1.43
g/l
2.14
224
412
272
540
7.60
142.84
2.8
1.7
—
—
—
0
0
359
978
6.47
134.98
15.0
6.0
1.07
1.03
mmol/l
1.36
353
909
196
295
8.83
131.56
2.9
1.5
8.60
12.07
iu/ml
—
14
8
94
42
25.69
130.95
3.4
1.9
512.01
642.62
e6/l
0.25
84
34
137
133
12.56
127.88
2.3
1.6
—
—
—
0
0
390
1204
6.05
125.79
8.4
3.5
0.80
0.82
mmol/l
1.44
380
1131
102
68
17.38
118.48
3.0
1.7
—
—
—
0
0
102
68
17.38
118.48
3.0
1.7
—
—
—
0
0
102
68
17.38
118.48
3.0
1.7
—
—
—
0
0
636
3147
12.01
117.39
24.6
6.5
24.15
26.71
%
4.51
629
2987
115
104
13.03
111.94
1.2
1.1
—
—
—
0
0
122
124
11.70
109.88
1.6
1.4
124.03
151.75
au/ml
1.08
39
39
646
3402
12.46
106.66
22.7
6.4
2.06
1.90
e9/l
0.29
623
2986
647
3455
12.33
103.88
24.7
6.5
0.15
0.20
e9/l
16.09
624
3005
59
14
45.92
99.17
1.2
1.4
—
—
—
0
0
307
916
5.18
98.83
12.6
8.4
10.63
11.93
kpa
5.30
295
888
307
916
5.18
98.83
12.6
8.4
4.78
5.12
kpa
8.26
296
884
300
902
5.07
95.12
12.3
8.5
1.23
1.00
mmol/l
0.48
252
749
77
48
17.90
92.06
1.5
1.2
—
—
—
0
0
178
347
6.54
91.85
2.5
2.0
1.56
1.48
g/l
0.37
150
308
138
209
7.98
90.42
1.9
1.7
—
—
—
0
0
653
3744
11.87
90.24
42.4
10.1
4.30
4.15
e9/l
0.85
628
3264
256
702
5.17
90.23
5.9
2.8
71.78
70.78
e9/l
0.14
194
532
638
3586
9.67
89.80
22.8
7.1
10.10
11.67
umol/l
4.35
632
3435
585
3066
6.49
88.61
15.5
5.4
32.68
35.30
g/l
19.80
570
2887
110
131
9.77
87.74
1.4
1.3
264.12
267.75
u/ml
0.03
77
72
123
186
7.81
80.33
2.0
1.7
—
—
—
0
0
613
3518
6.91
78.29
26.5
7.8
1.20
1.21
mmol/l
3.50
540
3040
85
84
11.38
77.35
3.5
4.0
—
—
—
0
0
46
11
44.68
76.86
1.8
1.4
—
—
—
0
0
247
742
4.60
76.10
9.4
3.8
1.88
1.94
mmol/l
0.08
221
638
229
649
4.76
76.02
3.2
2.2
371.58
382.06
nmol/l
0.21
224
608
313
1125
4.22
75.58
4.3
2.6
2.10
2.27
g/l
5.70
300
1044
577
3206
5.52
75.13
21.9
6.9
1.20
1.21
mmol/l
4.25
566
2947
324
1204
4.14
74.43
4.3
2.7
11.51
12.72
umol/l
2.65
315
1122
258
830
4.34
72.07
12.9
8.7
94.48
95.37
%
1.18
250
807
295
1056
4.10
70.85
4.4
2.6
22.28
22.59
%
0.15
288
990
59
39
16.43
68.13
5.9
3.4
1.61
0.85
%
1.79
59
39
90
115
8.83
67.46
8.9
4.0
1.41
1.33
%
0.06
85
105
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
124
236
6.17
64.41
3.7
2.6
0.38
0.35
iu/ml
0.34
82
132
239
784
4.11
64.02
14.7
9.0
113.42
121.16
g/l
5.88
234
768
68
67
11.13
61.74
2.4
2.4
24.09
60.70
iu/ml
—
11
7
362
1613
3.57
60.53
4.9
2.7
3.91
4.95
e6/l
1.01
354
1475
563
3332
4.50
60.52
18.5
15.3
1.21
1.27
inr
1.81
506
2755
112
206
6.28
60.10
1.5
1.5
0.59
0.10
iu/ml
0.40
18
36
119
236
5.87
59.00
2.0
1.3
—
—
—
0
0
386
1818
3.50
58.52
9.3
2.9
348.81
352.21
umol/l
0.25
368
1581
152
378
4.86
58.13
1.8
1.4
—
—
—
0
0
51
35
15.64
57.59
3.8
1.9
—
—
—
0
0
51
35
15.64
57.59
3.8
1.9
—
—
—
0
0
51
35
15.64
57.59
3.8
1.9
—
—
—
0
0
51
35
15.64
57.59
3.8
1.9
—
—
—
0
0
445
2305
3.55
57.49
6.6
3.5
52.69
84.49
e6/l
0.36
394
1792
45
27
17.74
54.36
4.1
2.1
—
—
—
0
0
45
27
17.74
54.36
4.1
2.1
—
—
—
0
0
402
2007
3.35
54.13
6.5
3.4
0.26
0.50
e6/l
2.89
348
1493
301
1270
3.40
53.51
3.2
1.5
2.30
2.62
g/l
1.14
240
752
45
28
17.11
53.38
4.1
2.0
—
—
—
0
0
48
35
14.65
52.37
1.3
1.1
—
—
—
0
0
609
3998
4.99
52.26
15.6
5.5
6.90
6.78
mmol/l
0.59
600
3820
116
255
5.25
51.03
9.6
3.9
64.92
73.98
mg/l
0.14
94
217
54
50
11.62
50.96
1.5
1.2
—
—
—
0
0
115
254
5.22
50.29
9.6
3.9
58.69
60.51
mg/l
0.04
94
219
494
2891
3.40
49.02
41.3
12.2
0.01
0.00
e9/l
0.58
439
2375
431
2370
3.13
46.82
10.3
3.8
2.32
2.35
mmol/l
5.02
414
2134
422
2298
3.10
46.56
4.9
3.2
2198.08
1297.61
ng/l
2.62
395
1980
315
1459
3.10
46.42
2.5
1.7
1.90
1.46
mg/l
0.61
279
1146
163
507
3.89
45.58
12.6
7.7
24.34
24.54
mmol/l
0.26
156
487
399
2125
3.04
45.48
4.0
2.8
63.48
61.79
u/l
0.11
383
1970
148
431
4.09
45.41
6.1
3.7
2.11
1.87
mmol/l
0.31
115
330
104
234
5.04
44.30
9.0
3.6
4.15
2.66
ratio
0.30
61
136
76
131
6.39
43.15
1.9
1.4
—
—
—
0
0
76
131
6.39
43.15
1.9
1.4
—
—
—
0
0
88
185
5.30
40.43
4.1
2.3
119.23
128.76
g/l
2.52
70
144
41
37
11.71
39.20
4.2
4.5
—
—
—
0
0
603
4262
3.97
38.79
8.5
4.8
1578.10
1204.69
e6/l
—
10
65
343
1797
2.78
38.42
3.0
2.3
3.20
2.94
mg/l
1.23
325
1529
106
274
4.38
37.83
2.2
2.1
42.67
38.26
u/l
0.96
99
244
105
273
4.35
37.17
2.3
1.8
8.33
8.11
iu/ml
0.03
25
65
65
112
6.29
36.81
6.1
6.2
12.01
11.62
mg/l
0.25
60
104
87
210
4.59
33.76
2.0
1.4
0.24
0.23
g/l
0.41
82
200
136
455
3.47
33.38
2.6
1.7
—
—
—
0
0
512
3426
2.83
33.32
7.1
4.0
0.00
0.00
estimate
-0.00
165
720
503
3348
2.78
32.84
4.3
2.7
—
—
—
0
0
177
704
3.03
32.48
2.7
2.4
0.22
0.21
g/l
1.27
162
657
154
567
3.20
32.28
4.5
3.2
182.12
198.22
ng/l
0.22
144
524
189
782
2.94
32.28
6.7
3.0
7.17
8.61
umol/l
0.55
170
704
513
3469
2.79
32.08
7.2
4.1
16.02
2.56
estimate
0.61
167
735
515
3491
2.79
32.02
7.2
4.1
0.00
0.46
estimate
0.52
156
677
124
404
3.51
31.63
2.1
1.2
222.92
283.31
u/ml
0.25
108
373
49
74
7.04
31.40
4.4
2.4
—
—
—
0
0
374
2193
2.51
31.30
8.0
3.4
36.14
33.73
u/l
0.32
366
2062
176
721
2.92
30.43
6.1
3.5
—
—
—
0
0
72
170
4.61
28.62
1.4
1.2
—
—
—
0
0
63
134
5.07
28.37
1.6
1.3
506.67
398.18
titre
—
6
11
307
1713
2.41
27.75
10.4
4.3
88.47
87.87
%
0.16
297
1692
143
548
3.02
27.66
6.8
4.2
110.85
85.83
ng/l
2.10
130
489
68
158
4.66
27.55
1.3
1.3
—
—
—
0
0
460
3078
2.44
27.22
6.9
3.0
—
—
estimate
—
0
0
260
1356
2.46
27.22
6.5
4.2
180.84
327.48
ng/l
1.07
238
1130
436
2870
2.37
26.47
5.3
3.0
339.89
147.93
ug/l
3.41
421
2640
33
39
8.83
25.95
11.1
6.8
49.22
53.12
u/ml
—
9
8
613
4761
3.29
25.92
13.0
4.6
22.05
12.94
mm/h
22.02
606
4416
32
37
9.01
25.58
1.6
1.6
—
—
—
0
0
32
37
9.01
25.58
1.6
1.6
—
—
—
0
0
72
190
4.11
24.72
4.2
3.2
3.34
1.70
index
1.17
38
109
242
1272
2.38
24.41
5.2
3.1
1.00
0.93
e6/l
0.10
154
705
225
1158
2.39
23.70
5.7
3.3
1.41
1.83
e6/l
0.60
139
590
70
187
4.05
23.62
1.5
1.3
—
—
—
0
0
75
214
3.80
23.07
1.9
1.3
—
—
—
0
0
110
423
2.90
20.82
7.2
2.7
1.19
1.18
%
0.02
110
423
48
107
4.74
20.39
4.9
2.2
32.77
32.76
pg
0.01
48
107
332
2113
2.09
19.85
2.1
1.7
17.75
20.34
nmol/l
2.82
303
1763
250
1432
2.16
19.71
5.1
3.2
2.47
2.46
mmol/l
0.82
234
1285
419
2917
2.08
19.50
3.9
2.5
76.92
78.36
nmol/l
0.55
406
2580
393
2676
2.07
19.39
6.6
4.1
32.63
75.36
ng/l
1.16
348
2059
61
171
3.81
19.20
1.9
1.5
—
—
—
0
0
35
62
5.89
19.16
1.5
1.3
—
—
—
0
0
140
638
2.49
18.83
3.9
2.6
38.89
35.64
u/l
0.37
126
534
39
79
5.17
18.50
1.1
1.1
—
0.74
—
0
13
30
49
6.35
17.78
1.6
1.2
3.34
0.23
u/ml
0.61
17
27
24
31
7.98
17.51
1.4
1.5
61.47
64.88
mg/l
0.06
19
24
26
14
19.23
17.43
1.8
1.3
—
—
—
0
0
76
267
3.07
16.78
5.5
3.8
1.53
1.35
mmol/l
0.68
71
261
80
290
2.99
16.72
6.2
2.6
1.37
1.52
g/l
0.10
71
257
197
1091
2.12
16.47
1.3
1.3
39.45
12.81
u/ml
1.70
54
413
23
11
21.56
16.06
1.4
1.0
—
—
—
0
0
268
1674
1.97
15.98
5.5
2.5
—
—
—
0
0
119
543
2.44
15.79
3.9
2.9
51.69
63.37
ml/min/173m2
1.89
49
234
51
146
3.69
15.56
1.8
1.2
113.60
10.40
e6/l
0.45
40
108
25
17
15.20
15.45
1.1
1.1
—
—
—
0
0
29
53
5.66
15.36
1.5
1.2
90.00
104.00
titre
—
6
10
283
1823
1.93
15.24
6.8
3.5
0.04
0.05
estimate
0.09
141
569
23
13
18.25
15.23
4.9
2.5
2.87
2.54
%
0.08
23
13
321
2163
1.89
15.00
3.7
2.2
103.24
245.94
u/l
3.57
310
2057
70
253
2.96
14.68
5.2
2.4
0.07
0.03
g/l
0.41
65
230
366
2584
1.87
14.67
7.3
4.1
0.01
0.01
estimate
0.09
149
598
200
1167
2.00
14.22
1.3
1.3
68.16
33.93
iu/ml
1.97
81
354
150
787
2.15
14.20
5.5
4.4
16.78
30.60
ug/l
0.40
123
664
41
108
3.97
14.06
1.2
1.3
—
—
—
0
0
199
1178
1.96
13.47
1.8
1.7
1205.02
1203.95
nmol/l
0.00
168
890
44
126
3.66
13.41
1.3
1.3
213.72
181.09
miu/ml
—
5
49
35
85
4.28
13.36
1.4
1.3
9.20
6.07
u/ml
0.15
15
29
46
137
3.52
13.23
6.1
3.0
13.77
8.91
pmol/l
1.24
46
137
66
246
2.86
13.08
5.5
2.4
0.00
0.00
g/l
-0.00
61
217
33
80
4.28
12.63
1.3
1.3
—
—
—
0
0
288
1961
1.80
12.34
7.2
4.2
0.00
0.01
estimate
0.78
140
664
51
170
3.16
12.28
2.5
3.2
30.91
34.40
umol/l
0.63
45
151
61
228
2.84
12.03
5.8
2.5
0.00
0.00
g/l
-0.00
61
216
21
36
5.98
11.85
1.0
1.1
—
—
—
0
0
50
172
3.05
11.42
1.4
1.2
—
—
—
0
0
18
13
14.17
11.01
1.8
1.0
—
—
—
0
0
669
6053
3.31
10.98
77.4
17.9
27.92
25.78
mg/l
1.54
663
5058
33
89
3.84
10.97
1.4
1.2
6.21
7.29
u/ml
0.12
14
41
21
39
5.52
10.93
1.3
1.2
5.62
6.76
u/l
0.35
16
32
21
22
9.80
10.81
3.4
2.0
0.60
0.59
mmol/l
0.19
21
22
23
47
5.03
10.80
2.5
1.3
—
—
—
0
0
22
26
8.70
10.60
1.1
1.1
—
—
—
0
0
48
171
2.94
10.33
1.4
1.2
—
—
—
0
0
116
619
2.05
10.29
2.3
2.5
7.67
6.67
ug/l
0.24
103
556
401
3104
1.68
10.13
2.5
2.2
91.50
95.34
pmol/l
1.00
267
1601
22
47
4.80
9.82
2.5
1.3
—
—
—
0
0
49
182
2.82
9.78
1.3
1.3
—
—
—
0
0
33
97
3.52
9.71
1.6
1.3
2536.23
1581.19
e6/l
0.59
26
63
22
31
7.29
9.56
2.2
2.1
62.27
65.73
ug/l
0.06
22
31
20
41
4.99
9.36
4.8
3.4
0.75
0.85
index
0.34
20
41
17
16
10.86
9.32
1.8
1.3
—
—
—
0
0
49
187
2.74
9.30
1.7
1.2
7.40
2.59
u/ml
—
6
21
111
609
1.98
9.06
3.7
2.5
0.40
0.45
e6/l
0.12
111
586
14
9
15.83
9.06
1.6
1.1
—
—
—
0
0
59
251
2.47
9.01
6.2
2.0
—
—
—
0
0
48
186
2.70
8.86
1.7
1.3
5.75
3.16
u/ml
—
8
31
52
210
2.59
8.85
2.0
1.3
—
—
—
0
0
24
63
3.91
8.30
1.2
1.4
—
—
—
0
0
40
147
2.83
8.16
1.8
1.2
32.98
53.66
u/ml
—
8
18
16
19
8.59
7.84
1.3
1.1
0.47
4.37
mmol/l
0.52
11
11
17
23
7.55
7.71
3.4
1.6
2.10
1.84
umol/l
0.44
17
17
29
93
3.21
7.49
2.7
1.4
—
—
—
0
0
21
54
3.98
7.48
1.1
1.1
128.00
101.57
pmol/l
0.64
21
54
481
4054
1.59
7.40
5.8
3.5
82.02
54.54
u/l
4.41
464
3770
18
42
4.37
7.25
4.2
1.8
—
—
—
0
0
63
305
2.17
7.17
4.1
3.9
461.30
4841.53
u/ml
0.74
57
264
28
91
3.16
7.08
2.8
1.4
—
—
—
0
0
46
197
2.43
6.96
1.9
1.6
—
—
—
0
0
28
93
3.09
6.84
2.7
1.4
—
—
—
0
0
26
83
3.21
6.77
1.7
1.3
60712.53
42921.40
e6/l
0.13
17
43
20
54
3.78
6.68
2.2
2.8
9.15
8.07
mmol/l
0.35
20
54
13
17
7.77
6.14
1.5
1.9
—
—
—
0
0
25
83
3.09
6.13
1.1
1.1
—
—
—
0
0
21
63
3.41
6.04
1.1
1.1
106.10
99.38
%
0.48
21
58
25
85
3.01
5.89
4.9
2.9
4.23
4.05
mmol/l
0.82
25
85
14
22
6.47
5.88
2.0
1.4
—
—
—
0
0
53
260
2.12
5.86
1.4
1.3
—
—
—
0
0
45
210
2.22
5.63
1.3
1.4
242.11
276.56
ug/g
0.54
28
127
19
56
3.46
5.62
1.1
1.0
—
—
—
0
0
25
88
2.91
5.56
2.8
1.4
—
—
—
0
0
25
88
2.91
5.56
2.8
1.4
—
—
—
0
0
17
47
3.68
5.51
1.1
1.1
—
—
—
0
0
25
89
2.88
5.46
2.8
1.4
—
—
—
0
0
24
84
2.92
5.40
5.0
3.0
1.18
1.19
mmol/l
0.47
24
84
14
25
5.69
5.39
1.4
1.4
2.14
3.82
mmol/l
1.61
14
20
48
235
2.12
5.35
3.6
1.9
—
—
—
0
0
24
85
2.89
5.29
5.0
2.9
106.17
105.20
mmol/l
0.42
24
85
15
30
5.09
5.28
3.7
2.4
97.60
106.37
%
0.32
15
30
16
35
4.65
5.20
2.8
1.2
—
—
—
0
0
16
35
4.65
5.20
2.8
1.2
—
—
—
0
0
18
55
3.33
5.05
1.3
1.1
—
—
—
0
0
12
20
6.08
4.93
5.3
1.2
—
—
—
0
0
193
1437
1.47
4.77
1.6
1.8
124706341.68
26113450.15
pmol/l
0.57
170
1168
12
21
5.79
4.77
1.3
1.2
—
—
—
0
0
13
26
5.07
4.65
7.7
3.3
233.00
206.54
u/l
0.33
13
26
126
863
1.56
4.61
1.6
1.5
—
—
—
0
0
7
5
14.12
4.58
2.7
6.4
—
—
—
0
0
7
5
14.12
4.58
1.1
1.4
—
—
—
0
0
35
161
2.24
4.57
1.8
1.4
12.56
8.05
u/l
0.74
24
122
9
11
8.27
4.57
1.4
1.1
—
—
—
0
0
666
6314
2.10
4.55
75.2
21.7
138.44
139.68
mmol/l
26.68
666
6200
19
66
2.93
4.36
1.2
1.2
—
79.00
—
0
6
111
756
1.56
4.15
3.6
2.5
236.15
127.25
ug/g
1.39
95
598
23
92
2.55
4.08
4.9
2.0
5562.65
5850.12
u/l
0.01
11
30
15
47
3.24
4.07
1.4
1.2
—
—
—
0
0
12
26
4.68
4.07
1.1
1.2
—
—
—
0
0
201
1548
1.42
4.06
7.0
4.3
1.02
1.02
kg/l
0.33
166
1054
58
335
1.80
4.06
2.6
3.6
3.91
4.50
pmol/l
3.94
51
289
7
7
10.08
4.01
1.1
1.4
—
—
—
0
0
7
7
10.08
4.01
1.3
1.1
—
—
u/ml
—
0
0
10
18
5.62
3.98
1.8
1.3
—
—
—
0
0
86
557
1.62
3.97
1.9
1.5
—
—
—
0
0
32
151
2.17
3.96
2.6
3.2
0.85
0.88
nmol/l
0.09
24
121
13
32
4.12
3.92
1.2
1.1
—
—
—
0
0
50
846
0.56
3.89
4.7
5.2
28.90
31.78
%
1.21
42
538
15
49
3.11
3.82
1.4
1.2
—
—
—
0
0
15
49
3.11
3.82
1.4
1.2
—
—
—
0
0
15
49
3.11
3.82
1.4
1.2
—
—
—
0
0
20
78
2.61
3.74
2.3
1.5
51.38
62.04
%
0.50
13
50
8
12
6.73
3.68
1.0
1.1
—
—
—
0
0
8
12
6.73
3.68
1.1
1.4
—
—
—
0
0
8
12
6.73
3.68
11.9
10.3
5.76
5.40
mmol/l
—
8
12
12
30
4.05
3.61
1.2
1.1
—
—
—
0
0
10
21
4.81
3.56
1.2
1.1
—
23.60
u/ml
—
0
5
7
9
7.84
3.56
1.0
1.0
—
—
—
0
0
15
52
2.93
3.48
2.5
1.8
0.90
2.00
u/field
—
10
28
13
37
3.56
3.41
1.0
1.1
—
—
—
0
0
37
198
1.92
3.31
2.5
1.5
7607.62
13074.80
e6/l
0.73
26
139
518
4737
1.36
3.14
5.0
4.2
14.91
14.95
pmol/l
0.12
491
4286
12
35
3.47
3.12
1.0
1.1
0.68
0.49
ratio
—
7
20
30
153
2.00
3.09
1.9
1.5
39.75
26.80
iu/l
0.84
23
125
5
5
10.06
2.98
1.0
1.0
—
—
—
0
0
12
38
3.19
2.86
1.1
1.4
—
—
—
0
0
8
18
4.48
2.80
1.0
1.2
—
—
—
0
0
8
18
4.48
2.80
1.0
1.1
—
—
—
0
0
10
28
3.61
2.79
1.1
1.0
—
—
—
0
0
15
60
2.53
2.71
1.4
1.2
—
—
—
0
0
13
49
2.68
2.63
1.5
1.3
—
—
—
0
0
13
49
2.68
2.63
1.5
1.3
—
—
—
0
0
7
15
4.70
2.60
6.7
8.7
5.26
5.35
kpa
—
7
15
9
25
3.63
2.58
1.6
1.3
—
—
—
0
0
6
11
5.49
2.55
2.7
1.2
—
—
—
0
0
44
274
1.65
2.44
4.5
3.4
49.75
111.24
u/ml
0.66
44
265
16
70
2.32
2.42
1.4
1.2
—
—
—
0
0
5
8
6.28
2.37
1.2
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
33
3.06
2.36
1.2
1.2
—
—
—
0
0
16
71
2.28
2.36
1.6
1.2
7379.91
288349.98
e6/l
1.34
11
51
11
39
2.85
2.35
1.3
1.7
—
—
—
0
0
6
13
4.65
2.27
5.8
9.5
10.53
10.68
%
—
6
13
5
9
5.59
2.21
1.6
1.1
102.60
85.56
%
—
5
9
8
25
3.22
2.10
1.1
1.1
—
—
—
0
0
26
148
1.79
2.01
1.3
1.6
221.00
302.53
mu/l
1.28
21
136
9
32
2.84
2.00
1.2
1.1
—
—
—
0
0
26
150
1.76
1.93
1.3
1.9
115.44
4.35
iu/l
—
8
52
672
6543
1.65
1.93
97.7
27.2
93.00
91.49
fl
11.73
672
6470
27
158
1.74
1.91
5.1
3.7
419.48
1934.43
u/ml
0.47
27
148
672
6545
1.65
1.90
100.7
27.8
36.92
40.38
%
56.32
672
6469
7
22
3.20
1.88
2.9
3.8
9.24
10.17
kpa
—
7
22
7
22
3.20
1.88
2.9
3.8
5.48
5.02
kpa
—
7
22
5
12
4.19
1.82
4.4
1.6
1.19
1.26
mmol/l
—
5
12
14
69
2.05
1.65
1.1
1.2
—
—
—
0
0
595
6164
0.77
1.65
6.3
6.3
2.52
2.62
mmol/l
2.13
549
5663
136
1617
0.80
1.51
2.3
3.4
0.67
0.75
ug/l
0.54
90
1104
614
5925
1.29
1.45
58.8
17.5
72.51
77.93
ml/min/173m2
6.51
606
5515
276
2475
1.19
1.45
6.1
4.3
14.35
8.96
mg/mmol
1.30
208
1558
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
50
366
1.39
1.39
1.2
1.2
35.50
146.71
u/ml
5.72
15
137
278
2504
1.18
1.37
5.7
3.5
6.61
7.72
mmol/l
4.30
256
2105
27
176
1.56
1.33
1.7
1.8
—
—
—
0
0
5
19
2.64
1.22
1.0
1.1
—
—
—
0
0
5
19
2.64
1.22
1.0
1.2
—
—
—
0
0
164
1430
1.19
1.16
1.3
1.3
0.71
1.27
u/ml
1.80
41
374
13
72
1.82
1.15
1.2
1.2
1.38
1.78
nmol/l
0.47
13
64
589
6060
0.82
1.07
5.8
5.5
4.42
4.51
mmol/l
1.36
549
5589
20
130
1.55
1.03
6.5
3.9
35.47
26.14
mg/l
0.44
15
88
5
22
2.28
1.03
1.4
1.0
—
—
—
0
0
13
75
1.75
1.03
3.1
3.0
3.27
5.66
nmol/l
0.56
13
75
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
7
36
1.95
0.97
1.9
2.3
—
—
—
0
0
199
2201
0.87
0.96
4.3
4.8
22.71
21.38
%
0.57
94
1103
587
6026
0.84
0.92
5.6
5.4
1.37
1.44
mmol/l
3.73
545
5520
13
78
1.68
0.92
1.1
1.3
0.17
0.19
nmol/l
—
6
58
9
55
1.64
0.73
1.3
1.3
40.27
31.14
u/l
—
9
45
9
144
0.62
0.70
1.1
1.2
1.64
1.51
g/l
—
9
144
79
682
1.18
0.67
1.9
1.8
1.77
1.57
%
0.86
66
582
588
6004
0.87
0.65
6.3
5.6
6.09
6.04
mmol/l
0.31
549
5457
6
36
1.67
0.56
1.7
1.6
121.42
154.69
pmol/l
—
6
36
24
185
1.31
0.56
2.3
2.6
167.35
112.99
ug/min
0.36
17
101
34
277
1.24
0.53
1.2
1.5
0.53
0.34
mg/l
0.57
17
129
6
98
0.61
0.52
2.3
1.5
—
—
—
0
0
6
40
1.50
0.51
1.2
1.1
—
19.59
—
0
17
34
410
0.82
0.50
1.6
2.1
—
—
—
0
0
12
167
0.71
0.49
2.1
1.9
178.75
223.59
pmol/l
0.73
12
157
16
212
0.75
0.49
1.9
1.9
46.69
40.57
nmol/l
0.36
16
203
260
2738
0.92
0.48
2.2
2.0
1.57
1.32
mmol/l
4.43
228
2252
11
78
1.42
0.43
2.5
2.8
34.67
19.78
mg/l
—
6
32
12
161
0.74
0.41
1.8
2.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.6
—
8.17
—
0
17
5
35
1.43
0.39
4.6
2.3
33.36
39.82
g/l
—
5
35
580
5884
0.92
0.35
8.0
7.1
39.98
39.88
mmol/mol
0.10
553
5468
33
380
0.86
0.32
1.5
2.0
—
—
—
0
0
575
5671
1.08
0.30
6.2
5.3
2.19
1.99
mu/l
0.81
540
5175
15
185
0.81
0.30
1.7
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
22.77
—
0
12
9
114
0.79
0.20
1.3
1.4
—
—
—
0
0
6
51
1.18
0.19
1.2
1.4
0.89
1.28
promille
—
6
42
571
5764
0.95
0.19
5.2
4.6
1.44
1.30
mmol/l
4.42
528
5236
281
2743
1.04
0.19
4.9
5.9
3.70
2.54
ug/l
0.65
255
2453
66
619
1.07
0.18
2.7
2.5
11.23
13.21
nmol/l
0.97
58
557
62
659
0.94
0.17
1.5
1.4
—
—
—
0
0
12
141
0.85
0.16
1.2
1.5
—
—
—
0
0
7
88
0.79
0.14
1.1
1.1
—
16.80
—
0
15
14
156
0.90
0.10
2.6
1.2
0.98
0.89
g/l
0.58
14
156
5
44
1.14
0.10
1.8
1.4
97.00
77.95
umol/l
—
5
44
14
151
0.93
0.05
1.1
1.1
—
9.03
—
0
12
80
787
1.02
0.03
25.6
7.5
—
—
—
0
0
29
292
0.99
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
5.97
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.6
—
85.24
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
24.50
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
0.50
—
0
6
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
-0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_PNEUMOCYSTOSIS_WIDE – Pneumocystosis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).